- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1746-1596
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Immunohistochemical analysis of PDK1 expression in breast cancer ; volume:9 ; number:1 ; day:16 ; month:4 ; year:2014 ; pages:1-3 ; date:12.2014
Diagnostic pathology ; 9, Heft 1 (16.4.2014), 1-3, 12.2014
- Urheber
-
Arsenic, Ruza
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1746-1596-9-82
- URN
-
urn:nbn:de:1111-2016080745682
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Arsenic, Ruza
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prognostic significance of p16 & p53 immunohistochemical expression in triple negative breast cancer
Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests
Immunohistochemical Evaluation of Cathepsin B, L, and S Expression in Breast Cancer Patients
Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies
Immunohistochemical basigin expression level in thyroid cancer tissues
Immunohistochemical evaluation of ROCK activation in invasive breast cancer
Immunohistochemical Predictors of Bone Metastases in Breast Cancer Patients
Synthetic MRI in breast cancer: differentiating benign from malignant lesions and predicting immunohistochemical expression status
Expression of TNF-superfamily members BAFF and APRIL in breast cancer: Immunohistochemical study in 52 invasive ductal breast carcinomas
BCL-2 expression aids in the immunohistochemical prediction of the Oncotype DX breast cancer recurrence score
Expression of matrix metalloproteinases and their inhibitors in different immunohistochemical-based molecular subtypes of breast cancer
Immunohistochemical analysis of Metadherin in proliferative and cancerous breast tissue
Prognostic significance of p16 & p53 immunohistochemical expression in triple negative breast cancer
Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests
Immunohistochemical Evaluation of Cathepsin B, L, and S Expression in Breast Cancer Patients
Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies
Immunohistochemical basigin expression level in thyroid cancer tissues
Immunohistochemical evaluation of ROCK activation in invasive breast cancer
Immunohistochemical Predictors of Bone Metastases in Breast Cancer Patients
Synthetic MRI in breast cancer: differentiating benign from malignant lesions and predicting immunohistochemical expression status
Expression of TNF-superfamily members BAFF and APRIL in breast cancer: Immunohistochemical study in 52 invasive ductal breast carcinomas
BCL-2 expression aids in the immunohistochemical prediction of the Oncotype DX breast cancer recurrence score
Expression of matrix metalloproteinases and their inhibitors in different immunohistochemical-based molecular subtypes of breast cancer
Immunohistochemical analysis of Metadherin in proliferative and cancerous breast tissue
Prognostic significance of p16 & p53 immunohistochemical expression in triple negative breast cancer
Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests
Immunohistochemical Evaluation of Cathepsin B, L, and S Expression in Breast Cancer Patients
Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies
Immunohistochemical basigin expression level in thyroid cancer tissues
Immunohistochemical evaluation of ROCK activation in invasive breast cancer
Immunohistochemical Predictors of Bone Metastases in Breast Cancer Patients
Synthetic MRI in breast cancer: differentiating benign from malignant lesions and predicting immunohistochemical expression status
Expression of TNF-superfamily members BAFF and APRIL in breast cancer: Immunohistochemical study in 52 invasive ductal breast carcinomas
BCL-2 expression aids in the immunohistochemical prediction of the Oncotype DX breast cancer recurrence score
Expression of matrix metalloproteinases and their inhibitors in different immunohistochemical-based molecular subtypes of breast cancer